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Skeletal muscle development involves an initial period of myoblast replication followed by a phase in which some
myoblasts continue to proliferate while others undergo terminal differentiation. The latter process involves the permanent
cessation of DNA synthesis, activation of muscle-specific gene expression, and fusion of single cells to generate
multinucleated muscle fibres. The in vivo signals regulating the progression through all these steps remain unknown.
Fibroblast growth factors (Fgfs) and Fgf receptors comprise a large family whose members have been shown to play multiple
roles in the development of skeletal muscle in vitro. Exogenously applied Fgfs are able to stimulate proliferation and
suppress myogenic differentiation in cell culture. We sought to determine the role played by Fgf-4 during limb myogenesis
in vivo. Fgf-4 transcripts are located at both extremities of myotubes whereas the mRNAs of one of the Fgf receptors, Frek,
are detected in mononucleated proliferating myoblasts surrounding the multinucleated fibres. Overexpression of mouse
Fgf-4 (mFgf-4) using a replication-competent retrovirus, RCAS, leads to a down-regulation of muscle markers followed by
an inhibition of terminal differentiation in limb muscles. Using quail/chick transplantations we were able to follow the
muscle cells and found a dramatic decrease in their number after exposure to mFgf-4. Interestingly ectopic mFgf-4
down-regulates Frek transcripts in limb muscle areas. We conclude that overexpression of mFgf-4 inhibits myoblast
proliferation, probably by down-regulating Frek mRNAs. This suggests a role for Fgf-4, located at the extremities of the
myotubes, where it could be responsible for the absence of Frek mRNA in the muscle fibre. © 2001 Academic Press
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All the myogenic cells forming the striated skeletal
muscles of the vertebrate body originate from the somites
(for a review, see Christ and Ordahl, 1995). The back and
intercostal muscles constituting the epaxial musculature
originate exclusively from the medial halves of the dermo-
myotomes, while cells derived from lateral dermomyo-
tomes migrate lateroventrally to produce the muscles of the
body wall and of the limb, forming the hypaxial muscula-
ture (Christ et al., 1977; Chevallier et al., 1977; Ordahl and
Le Douarin, 1992). Migrating cells express a number of
genes, including Pax-3 (Goulding et al., 1994; Williams and
Ordhal, 1994) and Msx1 (Houzelstein et al., 1999), whose
expression are thought to prevent muscle differentiation
during the migration step (Bendall et al., 1999). As soon as
the migration process is finished, progenitor cells aggregate
1 To whom correspondence and reprint requests should be ad-
dressed. E-mail: Duprez@infobiogen.fr.
56into dorsal and ventral muscle masses (Schramm and
Solurch, 1990). There is then a phase of muscle cell prolif-
eration. The myogenic program is triggered by the expres-
sion of the MRFs (myogenic regulatory factors), a family of
bHLH transcription factors, composed of Myf5, MyoD,
myogenin, and MRF4 (Weintraub et al., 1991). Skeletal
muscle differentiation is initiated when proliferating myo-
blasts withdraw from the cell cycle and subsequently syn-
thesise muscle-specific proteins. Postmitotic myoblasts
fuse to form multinucleated fibres. Muscle growth during
embryogenesis and postnatal life is the result of a balance
between the proliferation of myoblasts present in the
muscle masses and their differentiation into mature muscle
fibres. Skeletal muscle fibres are formed by two successive
waves of fusion, which have been referred to as primary and
secondary myogenesis (Kelly and Zachs, 1969). The primary
and secondary muscle fibres differ morphologically and
biochemically (Freddette and Landmesser, 1991). The dif-
ferences between these two types of fibres probably result
from the interplay between the intrinsic program of myo-
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57Fgf-4 and Chick Limb Myogenesisblasts to produce particular types of fibres and local envi-
ronmental cues, which include both innervation and
growth factors (DiMario and Stockdale, 1997; Edom et al.,
994; Edom-Vovard et al., 1998).
Signals regulating the in vivo progression through the
ifferent steps occurring during primary and secondary
yogenesis remain poorly characterised. The progression
hrough the discrete developmental steps can be recapitu-
ated by muscle cell lines, which have provided in vitro
odels for studying the control of growth and differentia-
ion. Fibroblast growth factors (Fgfs) comprise a family of at
east 18 polypeptides that mediate various biological re-
ponses through four high-affinity structurally related re-
eptor tyrosine kinases, FgfR 1 to 4 (Mason, 1994; Martin,
998; Xu et al., 1999). Fgfs are very potent inhibitors of
yoblast differentiation in vitro (reviewed in Olson, 1992).
erminal muscle differentiation in cell culture requires
emoval of specific mitogens such as Fgfs. Even in the
resence of the MRFs, terminal differentiation cannot occur
hile the cells are exposed to Fgfs or other growth factors
Yutzey et al., 1990; Yoshida et al., 1996). Although the
echanisms by which Fgf inhibits muscle differentiation
ave not been thoroughly defined, Fgfs have been shown to
ct at multiple points within the myogenic regulatory
athway. On the one hand, Fgfs have been shown to
ctivate myoblast proliferation (Lathrop et al., 1985; Han-
on et al., 1996; Pizette et al., 1996). On the other hand,
ndependently of their effects on cellular proliferation, Fgfs
uppress transcription of the MRF, MyoD (Vaidya et al.,
989), and myogenin (Brunetti and Goldfine, 1990; Fox and
wain, 1993) genes and suppress the expression of markers
f terminal differentiation (Spizz et al., 1986; Clegg et al.,
987). In addition, the differentiation of skeletal muscle in
ulture is accompanied by a complete and permanent loss
f Fgf receptors from the cell surface (Olwin and Hauschka,
988; Moore et al., 1991; Templeton and Hauschka, 1992;
alevy et al., 1994) and by a down-regulation of Fgf tran-
cripts (Moore et al., 1991; Halevy et al., 1994). Finally, in
ddition to inhibiting the expression of myogenic bHLH
roteins, Fgfs can silence the transcriptional activities of
hese factors (Li et al., 1992). In contrast, under different
xperimental conditions, Fgfs have also been shown to
ctivate myogenesis. Application of low concentrations of
gf-6 to the C2 myoblast cell line leads to an up-regulation
f some muscle differentiation markers whereas high con-
entrations of Fgf-6 down-regulate these markers and delay
uscle differentiation. (Pizette et al., 1996). Moreover, it
as also been shown by an in vitro clonal analysis that some
arly myoblast precursors of the chick limb require expo-
ure to Fgf in order to express subsequently their myogenic
henotype in vitro (Seed and Hauschka, 1988). Therefore,
epending upon the in vitro experimental procedure, Fgfs
an have opposite effects, suggesting a complex role for the
gfs during the different steps occurring during myogenesis.
While several members of the Fgf family are widely
xpressed in multiple tissues, Fgf-4 transcripts present a
pecific expression pattern in developing skeletal muscle
Copyright © 2001 by Academic Press. All rightNiswander and Martin, 1992; Drucker and Goldfarb, 1993).
mong the FgfRs, FgfR1, FgfR4, and Frek are expressed in a
pecific manner in various organs including skeletal
uscles during development (Orr-Urtreger et al., 1991;
artanen et al., 1991; Stark et al., 1991; Peters et al., 1992;
atsone et al., 1993; Marcelle et al., 1995; Grothe et al.,
996). Frek has been shown to decrease during myogenic
ifferentiation (Marcelle et al., 1995) whereas FgfR1 tran-
cripts can still be detected in postmitotic myotubes in
yotomes (Patsone et al., 1993; Grothe et al., 1996). The
resence of Fgf-4 mRNAs in postmitotic cells of chick
yotome (Niswander and Martin, 1992) during early stages
f chick development and in differentiated muscle cells in
ouse (Drucker and Goldfarb, 1993) would appear to be
ifficult to reconcile with the well-described role of Fgfs in
keletal muscle inhibition. Gene ablations by homologous
ecombination in mice have not proved very informative
oncerning Fgf function in muscle formation, since ho-
ozygous Fgf-4 and FgfR1 null mutations both cause early
eath (Feldman et al., 1995; Yamaguchi et al., 1994) and
omozygous FgfR4 null mutation exhibits no overt abnor-
alities (Weinstein et al., 1998).
In order to understand the role of chick Fgf-4 during chick
imb myogenesis in vivo, we overexpressed mouse Fgf-4
mFgf-4) using a replication-competent virus, RCAS. We
ound that ectopic expression of mFgf-4 leads to a down-
egulation of myogenic markers followed by an inhibition
f terminal muscle differentiation. Moreover, ectopic ex-
ression of mFgf-4 down-regulates Frek while it up-
egulates FgfR-1 transcripts. Chick Fgf-4 transcripts are
etected at the extremities of the postmitotic myotubes
rom E6, in the chick limb. In light of the location of the
ndogenous Fgf-4 transcripts, putative roles for Fgf-4 during
yogenesis are discussed.
MATERIALS AND METHODS
Chick Embryos
Fertilized eggs of the White Leghorn chicken (HAAS, Strasbourg,
France) and the Japanese quail (Chanteloup, France) were incubated
at 37°C. For the experiments, young embryos were staged accord-
ing to Hamburger and Hamilton (HH) (1951) while old embryos
were staged according to days in ovo. To facilitate comparisons, we
report both staging.
Production of Fgf-4/RCAS-Expressing or Control/
RCAS-Expressing Cells and Infectious
Recombinant Retrovirus Particles
The mFgf-4 coding sequence (kindly provided by Y. Mason) was
inserted in the sense orientation into the ClaI site of the
replication-competent retroviral vector, RCASBP(A) (Hughes et al.,
1987). The construction was named Fgf-4/RCAS. Retrovirus-
expressing cells were prepared for grafting as described by Duprez
et al. (1998). Briefly, chicken embryonic fibroblasts (CEFs) were
isolated from 10-day-old 0 line embryos (BBSRC, Institute for
Animal Health, Compton, Berkshire, UK) and grown in DMEM
s of reproduction in any form reserved.
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58 Edom-Vovard, Bonnin, and Duprez(Gibco, BRL) containing 8% (v/v) foetal calf serum and 2% (v/v)
chick serum supplemented with antibiotics. CEFs were transiently
transfected with retroviral recombinant DNA (Fgf4/RCAS or
RCAS alone) at the concentration of 1 mg/ml using Transfectam
(Gibco, BRL) according to the manufacturer’s instructions. Super-
natant of the transfected cells was collected and centrifuged at
72,000g for 2 h. The pellet containing the viral particles was
resuspended in 1% of the initial volume in order to concentrate the
virus 10-fold.
Grafting of Retrovirus-Infected Cells
Retrovirus-expressing cells were prepared for grafting as de-
scribed by Duprez et al. (1996a,1998). Implantation of mFgf4-
expressing cells in the flanks of E2 chick embryos produced
additional limb buds (data not shown), similar to those grown after
Fgf bead implantation (Cohn et al., 1995), showing that mFgf4-
xpressing cells produce functional protein in the chick. Pellets of
pproximately 50 mm in diameter were grafted dorsally into the
middle of limbs of embryos at different stages of development
(Stages 20–26) according the experiments (Figs. 2A, 5A, and 5D).
This type of graft leads to reproducible virus spread into the dorsal
muscle masses of the forearm region. At different times after
grafting, embryos were harvested and processed for in situ hybri-
disation to whole-mount or tissue sections or immunohistochem-
istry. Grafting control/RCAS-expressing cells does not led to any
change in cartilage formation (data not shown and see Duprez et
al., 1996a) and in muscle gene expression (data not shown; Duprez
et al., 1998; Delfini et al., 2000). Some embryos were stained with
alcian blue and cleared in methyl salicylate to reveal the cartilage.
Grafting of Quail Somites into Chick Embryos
All operations were performed in ovo on chick and quail em-
bryos containing 15–16 somites (stage 12). The last-formed somite
and a part of the unsegmented mesoderm corresponding to 5
somites in length were extirpated from a chick embryo and
replaced by the counterpart from a quail embryo at the same
developmental stage. After the operation, the eggs were incubated
at 37°C for another 72 h. Limbs from each chimeric embryos,
which have reached stage 22, were then processed for micromass
cultures.
In Situ Hybridisation to Whole Mounts and Tissue
Sections
Embryos were fixed in 4% (v/v) formaldehyde and processed for
in situ hybridisation to whole mounts and tissue sections as
previously described (Duprez et al., 1998). Each experiments was
performed on at least three embryos. The digoxigenin-labelled
mRNA probes were prepared as described: cFgf-4 (Niswander,
993); mFgf-4 (Mahmood et al., 1995); Pax-3 and MyoD (Duprez et
al., 1998); Frek (Marcelle et al., 1994); and FgfR1 (Wilke et al.,
1997).
Immunohistochemistry
Differentiated muscle and quail cells were detected on sections
using the monoclonal antibody against sarcomeric myosin heavy-
chain MF20 and the QCPN antibody, respectively (Developmental
Hybridoma Bank, University of Iowa, Iowa City, IA). The bromode- t
Copyright © 2001 by Academic Press. All rightoxyuridine (BrdU) was detected using a monoclonal antibody
(Amersham Life Sciences, diluted 1/100, v/v). Cell death was
detected by the TUNEL assay on 7-mm serial wax sections. The in
situ cell death detection POD kit (Boehringer–Mannheim) was
used, according to the manufacturer’s protocol.
Muscle Fibre Counts
Transverse sections of limbs grafted at E5, fixed at E8/E9, stained
with the MF20 antibody, were used to count muscle fibres.
MF20-positive cells were counted in 22 randomly selected fields of
4780 mm2 in the infected and control limbs. Counts performed in
he infected muscles were compared with those of the equivalent
ontrol muscles cut at the same proximodistal level. Numbers of
bres in the infected muscles were expressed as percentages of the
umber of fibres in the control muscles.
Cell Proliferation Analysis
To label cells during the S-phase, BrdU (Amersham Life Sci-
ences), at a final concentration of 10 mM, was injected into the
heart of E7 embryos in ovo. After 4 additional h at 37°C, the
embryos were fixed and processed for sectioning.
Micromass Cultures
Wing buds were dissected from stage 21/22 White Leghorn chick
embryos or chimeric quail/chick embryos. High-density micro-
mass cultures were prepared from mesenchyme as described by
Duprez et al. (1996b). Briefly, cells were plated in Ham’s F12
medium containing 10% (v/v) foetal calf serum and cultured
overnight. The next day, micromasses were cultured in the same
medium with 4 ml of concentrated virus Fgf-4/RCAS. After 3 days,
icromass cultures were fixed in 70% ethanol for 10 min and then
rocessed for immunohistochemistry. Cultures were stained for
artilage with alcian blue.
RESULTS
Fgf-4 Transcript Location during Chick Limb
Muscle Development
Fgf-4 transcripts were first detected in the limb, at the
sixth day of chick embryonic life (stage 28/29) at the
anterior and posterior extremities of muscle masses (data
not shown). At E10, when the splitting process is complete,
producing the 13 muscles of the wing (Shellswell and
Wolpert, 1977), Fgf-4 transcripts can be detected in all
eparated muscles (Fig. 1A), although with a peculiar re-
tricted pattern (Fig. 1C), compared to the uniform MyoD
xpression (Figs. 1B and 1D). In contrast to the mouse
ituation, where mFgf-4 mRNAs were not detectable after
13.5 (Drucker and Goldfarb, 1993), the chick Fgf-4 mRNAs
ere detected until E14 (data not shown). These data
ndicate that Fgf-4 mRNAs can be detected in primary and
econdary myotubes, the latter being visualised around
tage 34 (E8) (Fredette and Landmesser, 1991). In order to
etermine whether Fgf-4 transcript location was restricted
o a subpopulation of myotubes, as suggested by the pic-
s of reproduction in any form reserved.
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59Fgf-4 and Chick Limb MyogenesisFIG. 1. Fgf-4 transcripts are located at the extremities of the myotubes in the embryonic chick wing. Adjacent transverse sections were
hybridised with a DIG-labelled antisense probes for Fgf-4 (A, C) and MyoD (B, D) at embryonic day 10 (A–D). Longitudinal sections (E–H)
were hybridised with DIG-labelled antisense probe (purple) for Fgf-4 (E, F) or MyoD (G, H) and then incubated with the MF20 antibody,
ecognising all isoforms of myosin heavy chains (brown). (C, D, F, H) Higher magnifications of muscles from pictures (A, B, E, G)
espectively. p, posterior; a, anterior; D, dorsal; V, ventral. Bars: (A, B) 320 mm; (C, D) 64 mm; (E) 128 mm; (G) 128 mm; (F, H) 32 mm.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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60 Edom-Vovard, Bonnin, and Dupreztures from transverse sections (Fig. 1C), we performed in
situ hybridisation on longitudinal sections of wing muscles
at E10, followed by immunohistochemistry using the MF20
antibody to visualise the muscle fibres. The MF20 antibody
recognises the myosin heavy chains (MyHC) expressed only
by differentiated myogenic cells. These experiments show
that Fgf-4 transcripts are expressed by all differentiated
myotubes, the expression domain being restricted to the
extremities of these cells (Figs. 1E and 1F) while MyoD
transcripts are distributed throughout the fibres (Figs. 1G
and 1H). The impression given by the transverse sections
that Fgf-4 only being expressed in some cells (Figs. 1A and
1C) is simply due to the fact that the section plan intersects
some myotubes at their ends and others at their centres.
Overexpression of mFgf-4 Induces Hypertrophy of
the Wing without Affecting Cartilage Patterning
The role of Fgf-4 in muscle development was investigated
by overexpressing mFgf-4 using a replication-competent
retrovirus, RCAS, in the limb bud. Aggregates of Fgf-4/
RCAS-expressing cells (see Materials and Methods) were
grafted to the limb mesenchyme of stage 20/21 (E3.5; E4)
wing buds (Fig. 2A) at a time when migration process
was complete (Christ et al., 1977; Chevalier et al., 1977;
Chevalier et al., 1978). The phenotype of such manipulated
embryos was analysed 6 days later, at E10. These grafts
resulted in formation of swollen and abnormally shaped
right wings (n 5 15; Fig. 2B) compared to the contralateral
left wing from the same embryos (Fig. 2C). Analysis of the
skeletal elements shows that no change of cartilage pattern
occurs after such grafts (compare the digits in Fig. 2B with
those in Fig. 2C). Embryos grafted with control/RCAS-
expressing cells did not exhibit any change in cartilage
morphology (data not shown and see also Duprez et al.,
1996a, 1998).
Overexpression of mFgf-4 Down-Regulates Muscle
Markers in Vivo
In order to determine the consequence of mFgf-4 overex-
pression on muscle, we looked for different muscle markers
at different stages after grafting. In situ hybridisation to
mFgf-4 transcripts in whole-mount preparations showed
the extent of the virus spread, 48 h after grafting (n 5 9; Fig.
A, arrow). The use of mFgf-4 allowed us to discriminate
etween ectopic mouse and endogenous chick Fgf-4. In
imilar grafted embryos, MyoD expression is down-
egulated in the grafted area (n 5 5; Fig.3B, arrow). Five
ays after grafting, the operated embryos (n 5 4) were cut
ransversely through the forelimb region and hybridised
ith the mFgf-4 probe, showing the extent of the virus
pread (Fig. 3D). Adjacent sections hybridised with the
yoD probe show a clear down-regulation of MyoD tran-
cripts in the dorsal muscle area (Fig. 3E) where mFgf-4
s present (Fig. 3D). We can nevertheless detect MyoDRNAs in the EMU (Fig. 3E, arrow) despite the presence of E
Copyright © 2001 by Academic Press. All rightctopic mFgf-4 transcripts in that muscle (Fig. 3D, arrow),
uggesting that ectopic mFgf-4 acts in a specific window of
ime (see next paragraph). The down-regulation of MyoD
RNAs is accompanied by an inhibition of terminal differ-
ntiation, assayed by myosin protein expression since only
wo dorsal muscles, EMU and a small part of the EMR can
e observed in the wing (Fig. 3F). The control wing shows
he normal muscle pattern assayed by MyoD (data not
hown) and myosin expression (Fig. 3C). The dorsal
uscles, running from the posterior to the anterior, the
FIG. 2. Limb phenotype after grafting Fgf4/RCAS-expressing-
cells. Fgf4/RCAS-expressing cells were grafted to the middle of the
wing of stage 20/21 wing buds (A). Whole-mount preparations were
stained with alcian blue on embryonic day 10. The grafted right
wing displays a hypertrophy (B) compared to the contralateral left
wing from the same embryo (C). Bar, 1.9 mm.MU, EDC, EML, EIL, and EMR are all present (Fig. 3C). In
s of reproduction in any form reserved.
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61Fgf-4 and Chick Limb Myogenesisconclusion, overexpression of mFgf-4 down-regulates the
xpression of the myogenic factor MyoD and consequently
nhibits terminal muscle differentiation.
Pax-3 is considered as acting upstream of MyoD in
yogenesis (Tajbakhsh et al., 1997; Maroto et al., 1997;
endall et al., 1999). We investigated whether ectopic
FIG. 3. Overexpression of mFgf-4 down-regulates MyoD tran
whole-mount preparations by in situ hybridisations with a probe ag
The distribution of MyoD transcripts in whole-mount preparatio
transcripts indicated by an arrow, in the grafted area. Five days afte
mFgf-4 (D) show the extent of the virus spread. Consecutive sect
antibody (F) show the down-regulation of muscle markers in the inf
MF20 display the normal muscle pattern (C). u, ulna; r, radius; EM
digitorum profundus; EML, extensor medius longus; EIL, extenso
metacarpi radialis. Bars: (A, B) 100 mm; (C–F) 320 mm.Fgf-4 could affect myogenesis at an earlier step by exam- t
Copyright © 2001 by Academic Press. All rightning Pax-3 expression after grafting. Twenty-four hours
fter grafting Fgf-4/RCAS-expressing cells (Fig. 4A, ectopic
Fgf-4 is arrowed), the expression of Pax-3 transcripts was
own-regulated in the grafted area (n 5 3; Fig. 4B, arrow). In
rder to confirm that the down-regulation we observed after
hole-mount in situ hybridisation was not just located to
ts and myosin expression. Viral transcripts were detected in
t mFgf-4, 48 h after grafting Fgf4/RCAS-expressing cells (A, arrow).
48 h after similar grafts (B), shows a down-regulation of MyoD
ting, transverse sections from a grafted right wing hybridised with
hybridised with MyoD probes (E) and incubated with the MF20
areas. Transverse sections of contralateral left wings labelled with
extensor metacarpi ulnans; FCU, flexor carpi ulnaris; FDP, flexor
idis longus; EDC, extensor digitorum communis; EMR, extensorscrip
ains
ns,
r graf
ions
ected
U,
r inche grafted cells themselves, we carried out in situ on
s of reproduction in any form reserved.
c62 Edom-Vovard, Bonnin, and Dupreztransverse wing sections, 20 h after grafting. In such experi-
ments, mFgf-4 transcript location cannot be attributed only
to the grafted cells but reveals the virus spread (Fig. 4C,
arrow). Cells that expressed mFgf-4 in muscle masses failed
to express Pax-3 (n 5 5; Fig. 4D, arrow).
Overexpression of mFgf-4 Is Able to Inhibit
the Formation of Primary and Secondary
Myogenic Fibres
Skeletal muscle is formed through the differentiation and
fusion of myoblasts in two successive waves of multinucle-
ated fibres termed primary and secondary fibres (Hauschka,
1994). The primary fibres begin to form at stage 20 (E3),
whereas the secondary fibres form between stages 31 and 41
(E7 and E15) (Fredette and Landmesser, 1991). We sought to
determine whether ectopic mFgf-4 could affect both fibre
types. Grafting Fgf-4/RCAS-expressing cells at E3 (Fig. 5A)
leads to a complete disappearance of differentiated muscle
cells (n 5 4; Fig. 5B) compared with the equivalent muscle
from the contralateral wing (Fig. 5C), 4 days after grafting.
Analysis of grafts at E5 (n 5 4; Fig. 5D), when primary
fibres are already in place in the limb (Fredette and Land-
FIG. 4. Overexpression of mFgf4 down-regulates Pax3 expression
at stage 21HH, mFgf-4 (A) and Pax3 (B) transcripts were detected i
sections were prepared from manipulated embryos, 20 h after gra
indicate the virus spread (A, C) and the down-regulation of Pax-3
150 mm; (C, D) 128 mm.messer, 1991), shows that ectopic mFgf-4 (Fig. 5E, in purple,
Copyright © 2001 by Academic Press. All rightarrowhead) is never detected in the differentiated muscle
cells (Fig. 5E, in brown, arrow). Moreover, the mFgf-4/
RCAS-infected muscles contain less fibres (Fig. 5D) than
the same muscles in the contralateral wing (Fig. 5F). By
counting muscle fibres, we found that the mFgf4/RCAS-
infected muscles contain 72.4 6 2.2% (mean 6 SEM) fibres
compared to the equivalent control muscles. The new fibres
surrounding the primary fibres can be observed in the
equivalent muscle of the contralateral wing (Fig. 5F, arrow-
head and arrow, respectively). These results show that
ectopic mFgf-4 affects the formation of new fibres but does
not affect the fibres that are already formed in the limb.
Given the timing of the endogenous expression of Fgf-4
transcripts (Fig. 1), it probably acts only during the second-
ary fibre formation.
mFgf-4 Inhibits Cartilage and Muscle
Differentiation in Vitro
In order to analyse the nature of the mFgf-4 effect on limb
muscle development, we first investigated whether mFgf-4
ould have a similar effect in vitro. Micromass cells cul-
tures mimic limb development in vitro (Arhens et al.,
mb muscle masses. 24 h after grafting Fgf4/RCAS-expressing cells
ole-mount preparations by in situ hybridisation. Adjacent sagittal
and hybridised with mFgf-4 (C) and Pax3 (D) probes. The arrows
cripts in the grafted areas (B, D). D, dorsal; V, ventral. Bars: (A, B)in li
n wh
fting
trans1977). Micromass cell cultures were prepared from stage
s of reproduction in any form reserved.
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63Fgf-4 and Chick Limb Myogenesis21/22 (E4) chick limb embryos and treated with concen-
trated Fgf-4/RCAS virus for 3 days. The untreated cultures
presented numerous nodules of cartilage, as determined by
alcian blue staining surrounded by MyHC-expressing cells
(n 5 20; Figs. 6A and 6B). In the cultures treated with
gf-4/RCAS virus, there was a decrease (n a 5 10) or a
disappearance (n b 5 10) of both differentiated myotubes and
cartilage nodules (n a 1 n b 5 20 of 20; Figs. 6C and 6D). It
as already been shown that addition of Fgf2 reduces the
umber of differentiated muscle cells in micromass cul-
ures (Schofield and Wolpert, 1990). In conclusion, ectopic
Fgf-4 inhibits muscle differentiation in vitro.
mFgf-4 Leads to a Decrease in Muscle Cell Number
in Vitro
Addition of mFgf-4 leads to an inhibition of muscle
FIG. 5. Ectopic mFgf-4 inhibits the formation of new fibres. Right
grafted with Fgf4/RCAS-expressing cells and fixed 4 days later. Tran
at the same level along the proximodistal axis were successively
antibody (brown). Pictures show the equivalent muscle areas in the
in E indicates a primary fibre (brown) and the arrowhead shows a
detected in differentiated fibres. We can observe primary (F, arrow)
Bar (B, C, E, F), 32 mm.differentiation in vitro and in vivo. One question we could M
Copyright © 2001 by Academic Press. All rightask is what do the muscle cells become under mFgf-4
exposure? Do muscle cells proliferate and subsequently not
differentiate? Based on Fgf studies on muscle cell lines
(Olson, 1992), we expected an augmentation of proliferation
of undifferentiated muscle cells. Since muscle cells consti-
tute a cell lineage separate from cartilage and connective
tissues (Chevalier et al., 1977; Christ et al., 1977), we can
ollow the fate of muscle cells by somite transplantation
xperiments. We replaced the chick presumptive wing
omites with their counterpart from a quail embryo at the
ame developmental stage (see Materials and Methods).
uscle cells will then be of quail origin and could be
ollowed during development using the QCPN antibody.
e unsuccessfully tried to graft such chimeric embryos
ith Fgf-4/RCAS-expressing cells, the two successive ma-
ipulations being fatal for the embryos. We therefore per-
ormed micromass cultures from those chimeric wing buds.
s from embryos at E3 (Stage 20) (A–C) and E5 (stage 25) (D–F) were
se sections of grafted wings (B, E) and of the control wing (C, F) cut
idised with mFgf-4 probe (purple) and incubated with the MF20
tralateral wings (C, F) and the manipulated wings (B, E). The arrow
infected with mFgf-4/RCAS (purple). Note that mFgf-4 is never
secondary (F, arrowhead) fibres in the contralateral muscle, at E9.wing
sver
hybr
con
cell
andicromass cultures in the presence of mFgf-4 exhibited a
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64 Edom-Vovard, Bonnin, and Duprezdecrease in cartilage nodules and in differentiated muscle
cells, assayed by MF20 staining (Figs. 7D–7F), compared to
the control culture (Figs. 7A–7C), as described in the legend
to Fig. 6. Unexpectedly, the number of QCPN-positive cells
normally incorporated in the myotubes in the control
cultures (n 5 8; Figs. 7B and 7C, arrows) dramatically
decreases in the mFgf-4-treated cultures (n 5 8 of 8; Figs. 7E
and 7F, arrows). This result shows that the inhibition of
muscle differentiation we observed in mFgf-4-treated cul-
ture is the consequence of the down-regulation of muscle
cell number. It should be noted that the majority of the
QCPN-positive cells left in the mFgf-4-treated cultures are
not expressing myosin (Fig. 7F, arrows). In light of this
result, the down-regulation of muscle markers observed
after overexpression of mFgf-4, in vivo, can be interpreted
differently: the absence of muscle markers could be the
consequence of a decrease in the number of progenitor cells.
Misexpression of mFgf-4 Does Not Induce Massive
Apoptosis in the Limb
We investigated whether the decrease of number of
muscle cells following exposure to mFgf4 was the conse-
FIG. 6. Addition of mFgf-4 to micromass cultures of stage 21/22
Three-day micromass cultures (n 5 40) were grown in medium al
0). Cultures were stained with monoclonal antibody MF20 show
evealing the nodules of cartilage. Bars: (A, C) 1 mm; (B, D) 60 mmquence of apoptosis. We found no increase of cell death in
Copyright © 2001 by Academic Press. All righthe mFgf4-infected area (n 5 2; Figs. 8A and 8B). Cell death
s observed in discrete region (Figs. 8C–8E) of the limb
ndependently of the presence of mFgf-4. We therefore
onclude that the decrease of muscle cell number observed
fter misexpression of mFgf-4 is not due to cell death, but is
robably due to an absence of muscle cell proliferation.
Ectopic mFgf-4 Down-Regulates Frek While
Up-Regulating FgfR1 Transcripts
Frek expression has already been correlated with myo-
blast proliferation (Halevy et al., 1994; Marcelle et al.,
1995). We detected Frek transcripts in mononucleated cells
(Fig. 9A, in purple, arrowheads) located along the myotubes
(Fig. 9A, in brown, arrow); and some Frek-positive cells
incorporated BrdU (Fig. 9B, arrowheads). FgfR1 transcripts
are detected uniformly in regions surrounding cartilage,
connective tissue, and muscle cells (Figs. 9C and 9D; Peters
et al., 1992).
In situ hybridisation in whole-mount preparations
showed that the expression of Frek transcripts is down-
regulated (n 5 6) while that of FgfR1 is up-regulated (n 5
wing bud mesenchyme inhibits muscle and cartilage formation.
A, B; n 5 20) or with the addition of Fgf4/RCAS virus (C, D; n 5
the differentiated muscle cells (brown) and then with alcian bluechick
one (
ing4), 24 h after grafting (Figs. 10A and 10B, arrows). Seventy-
s of reproduction in any form reserved.
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65Fgf-4 and Chick Limb Myogenesistwo hours after grafting, we observed a disappearance of
Frek mRNAs (n 5 4; Figs. 10F and 10K) in the mFgf-4-
ositive areas (Figs. 10D and 10I) whereas FgfR1 transcripts
re up-regulated in the same areas (Figs. 10H and 10M). Frek
Figs. 10E and 10J) and FgfR1 (Figs. 10G and 10L) mRNAs
FIG. 7. Application of mFgf-4 to micromass cultures of wing from
the number of quail cells. Presegmental plate of the presumptive re
implanted at the same position in chick hosts. Manipulated emb
independently from each chimeric wing (n 5 4). Three-day micr
presence of Fgf4/RCAS virus (n 5 8; D–F). Cultures were double
nuclear protein (brown) and MF20 (blue). Nodules of cartilage were
the whole cultures. Higher magnification of micromass cultures sh
blue) (B). Higher magnifications of the quail nuclei show their dis
culture, there is a decrease in the number of MF20-positive cells (E
arrowed). Bars: (A, D) 1 mm; (B, E) 60 mm; (C, F) 30 mm.re present in the equivalent muscle masses of the con- s
Copyright © 2001 by Academic Press. All rightralateral wing cut at the same level along the proximodis-
al axis (Fig. 10C). In addition, we observed an up-regulation
f Frek and FgfR1 transcripts in cartilage regions (Figs. 10F
nd 10H, arrows) in the presence of ectopic mFgf-4 in those
egions (Fig. 10D) reflecting either a tissue-dependent re-
meric quail/chick embryos leads to a dramatic down-regulation in
s of the wing muscles were excised from quail donor embryos and
were incubated for 3 days and 4 micromass cultures were set up
s cultures were grown in medium alone (n 5 8; A–C) or in the
ed with the monoclonal antibodies QCPN directed against quail
ned by alcian blue. Low magnifications (A, D) give an overview of
he presence of myotubes (blue) surrounding cartilage nodules (sky
tion in the differentiated cells (C, arrows). In the mFgf-4-treated
of QCPN-positive cells (F; the remaining QCPN-positive cells arechi
gion
ryos
omas
stain
stai
ow t
tribu
) andponse of Frek to the Fgf signal or a different response of
s of reproduction in any form reserved.
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66 Edom-Vovard, Bonnin, and DuprezFrek to different concentrations of Fgf, as already suggested
y in vitro studies (Halevy et al., 1994).
DISCUSSION
Overexpression of mFgf-4 Inhibits Myogenesis
in Vivo and in Vitro
Exposure of chick limb muscle cells to mFgf-4 prevents
myogenesis in vivo and in micromass cultures. Our results
are consistent with the well-described effect in the litera-
ture of Fgfs on muscle cell lines (see Introduction). This is
the first time that an effect of Fgf-4 on limb myogenesis in
vivo has been reported. Fgf virus injections in presumptive
limb somites have been already undertaken but did not lead
to any limb muscle phenotype (Itoh et al., 1996), possibly
because the use of a replication-defective virus may have
resulted in a lesser extent of infection or because of a
different timing of injection. However, misexpression of
Fgf5 in later limbs led to a similar inhibition of MyoD and
FIG. 8. Overexpression of mFgf-4 does not lead to an increase of
ransverse sections of E5 limb, 2 days after grafting, using the mFg
he consecutive section (B). High magnification of dorsal (C), v
ndependently of the presence of mFgf-4. Arrows indicate cell deatmyosin expression (Clase et al., 2000).
Copyright © 2001 by Academic Press. All rightOverexpression of mFgf-4 Halts Proliferation
of Muscle Cells
Addition of mFgf-4 leads to a down-regulation of all the
muscle markers (early to late) that we tested, making it
difficult to interpret the results. The only muscle cell
marker left to us was the embryological marker. By using
quail/chick transplantations, we found a dramatic diminu-
tion of the number of quail cells under mFgf-4 exposure, in
vitro. Analysis of apoptosis experiments showed that
misexpression of mFgf-4 does not induce generalised cell
death. The decrease in muscle cell number and the absence
of cell death leads to the conclusion that exposure to mFgf4
prevents muscle cell proliferation. This absence of muscle
cell proliferation can be explained by the down-regulation
of Frek transcripts we observed after overexpression of
mFgf-4. Frek protein has already been shown to maintain
muscle progenitor cells in a proliferating state (Halevy et
al., 1994; Marcelle et al., 1995). The biphasic regulation of
Frek and FgfR1 transcripts in muscle cells after exposure to
mFgf-4 calls the situation during development of the mouse
death. Viral transcripts were detected by in situ hybridisation on
robe (A) and cell death was revealed by the TUNEL technique on
al (D), and posterior (E) regions show that there is cell death
rs: (A, B) 140 mm; (C–E) 63 mm.cell
f-4 p
entrskull vault (Iseki et al., 1999). In this system, addition of
s of reproduction in any form reserved.
s
w
t
k
(
w
m
t
w
p
n
c
b
1
s
(
m
m
t
d
l
r
e
a
e
s
(
i
i (C) 1
67Fgf-4 and Chick Limb MyogenesisFgf-2 down-regulates FgfR2 while up-regulating FgfR1 tran-
cripts, expressions of FgfR2 and FgfR1 being associated
ith proliferation and differentiation, respectively (Iseki et
al., 1999).
Phenotype of the Limb Bud after mFgf-4
Overexpression
The mFgf-4-manipulated wings showed an enlargement
compared to the contralateral wings, corresponding to an
increase of tissue. Since we show that there is no increase of
muscle cell proliferation, another lineage must be affected.
Whole-mount and in situ tissue section analysis showed
hat cartilage is not modified (see Figs. 2, 3, and 10). Fgfs are
nown to control vascular endothelial cell proliferation
Folkman and Klasgsbrun, 1987; Cox and Poole, 2000), and
e indeed noticed a disorganised vasculature where ectopic
Fgf-4 was applied (data not shown). It is not clear whether
he disorganised vessels could account for the phenotype
e observed. Fgf probably also affects mesenchymal cell
roliferation, leading to an augmentation of the loose con-
ective tissue of the limbs (see Figs. 3 and 9). Fgfs were first
haracterised 25 years ago as mitogens of cultured fibro-
FIG. 9. Comparison of Frek and FgfR1 transcript expression doma
ections of E7 limb hybridised with the Frek probe (purple) and inc
arrowheads) are never located in myotubes (arrow). (B–D) Frek
mmunohistochemical bromodeoxyuridine (BrdU) uptake is stain
ndicate Frek1/BrdU1 cells (B) and FgfR11/BrdU1 cells (D). Bars:lasts, hence their names (Gospodarawicz and Moran, t
Copyright © 2001 by Academic Press. All right975). Moreover, it has recently been shown that Fgf5
timulates expansion of the connective tissue fibroblasts
Clase et al., 2000). Feather formation is disrupted by
isexpression of mFgf-4 as already shown by Jung et al.
(1998).
Ectopic mFgf-4 Inhibits Cartilage Formation
in Micromass Cultures
In addition to inhibition of myogenesis, mFgf-4 prevents
cartilage nodule formation in micromass cultures. Since
chondrogenesis and myogenesis proceed independently of
each other in micromass cultures (Swalla and Solursh,
1986), Fgf-4 must therefore act directly on each cell type.
No effect on cartilage was observed in our in vivo experi-
ents (see results). This discrepancy can be explained by
he micromass culture technique in which the cell-
issociation step may affect cellular development so as to
eave cells at a more immature stage than that of embryo
emoval (Archer et al., 1984). In our in vivo experiments,
ctopic mFgf-4 only reaches cartilage cells once they are
lready engaged in cartilage differentiation, which could
xplain the lack of cartilage defect (see Results). However,
cording to their proliferative state in E7 chick limbs. Longitudinal
ed with the MF20 antibody (brown) (A) show that Frek transcripts
FgfR1 mRNAs detected by in situ hybridisation (purple) and
brown on longitudinal sections from E7 limbs. The arrowheads
28 mm; (A, B, D) 32 mm.ins ac
ubat
and
ed inhe cartilage seems responsive to Fgf-4 signalling since we
s of reproduction in any form reserved.
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68 Edom-Vovard, Bonnin, and DuprezFIG. 10. Overexpression of mFgf-4 down-regulates Frek while up-regulating FgfR1 transcripts. Twenty-four hours after grafting
gf4/RCAS-expressing cells at stage 21HH, Frek (A) and FgfR1 (B) transcripts were detected in whole-mount preparations by in situ
hybridisation. Arrows indicate the down-regulation of Frek (A) and up-regulation of Fgfr1 transcripts (B), in the right grafted wings. Adjacent
ransverse sections prepared from contralateral and manipulated wing (C) at 7.5 days of development were hybridised with mFgf-4 (D) and
Frek (E, F) probes (purple) and then incubated with MF20 antibody (brown) or only hybridised with FgfR1 probe (G, H) (purple). The insets
(I–M) in the top right corners of panels (D–H) show 3.53 magnifications of the regions indicated by rectangular outlines in the main panels.
In control wing (E, G), this region contains the anterodorsal muscle mass expressing Frek (E, J) and FgfR1 (G, L). The equivalent region
infected with mFgf4 (D, I) has down-regulated Frek (F, K) while FgfR1 is up-regulated (H, M). Note a few remaining Frek1 and MF201 cells
in K. Arrows indicate the up-regulation of Frek (F) and FgfR1 (H) transcripts in cartilage region. Bars: (A, B) 200 mm; (D–H) 128 mm.
69Fgf-4 and Chick Limb Myogenesisobserved an up-regulation of Frek and FgfR1 transcripts in
cartilage regions after mFgf-4 overexpression. Moreover,
localised application of Fgf-2 (basic Fgf) to the anterior
margin of the wing buds affects cartilage patterning by
causing partial duplication of digit two (Riley et al., 1993).
We never observed a cartilage patterning defect, due to our
experimental design of grafting in the middle of the limb.
Hypothesis Concerning the Role of Endogenous
Fgf-4 during Limb Myogenesis
Muscle differentiation is correlated with a down-
regulation of Fgf receptors in vitro (Moore et al. 1991;
Halevy et al., 1994). The first evidence that the down-
regulation of FgfR occurs in vivo came from the work of
Itoh et al. (1996). The in vivo signal responsible for the
down-regulation of FgfRs is unknown. We propose that
Fgf-4 could be one of the in vivo signals inducing the
decline of the Frek mRNAs that is necessary for terminal
muscle differentiation. It is not clear which Fgf receptor
transduces the response to Fgf-4. There is evidence that
FgfR1 signalling is necessary to maintain myoblast number
(Flanagen-Steet et al., 2000). Moreover, we observed an
up-regulation of FgfR1 transcripts after overexpression of
mFgf-4 (see Results). One hypothesis is that Fgf-4 acts via
FgfR1 signalling to down-regulate Frek expression.
During rat embryogenesis (Zhang and McLennan, 1995)
and perinatal period (Kitiyakara and Angevine, 1963), there
is evidence that fusion of myoblasts occurs at the ends of
primary and secondary myotubes. In order to fuse, myo-
blasts need to exit from the cell cycle. One hypothesis is
that Fgf-4 would inhibit the proliferation of the surrounding
myoblasts, by down-regulating Frek expression in those
cells. The postmitotic myoblasts would then be incorpo-
rated at the extremities of the fibres. Fgf-4 located at the
extremities of the myotubes would be involved in this
preferential incorporation of myoblasts at the end of fibres.
It has been observed that myotubes are arranged in a
highly structured array in the orientation which predicts
the fibre orientation of the future muscles (Kardon, 1998).
Individual tendons are first distinguishable as discrete re-
gions adjacent to their forming partner muscle insertion
heads/origins from stage 26/27 in the chick leg (Kardon
1998). While muscles and tendons initiate their develop-
ment independently (Shellswell and Wolpert, 1977; Kieny
and Chevallier, 1979; Kardon, 1998), it has been shown that
further development of the tendons requires the presence of
the muscle (Kardon, 1998). Fgf-4 located at the extremities
of the myotubes in the fibres, which prefigures the future
insertion sites between muscles and tendons, could be the
muscle factor responsible for the maintenance of the ten-
don primordia during development.
In conclusion, Fgf signalling is involved in multiple
processes, including proliferation, survival, differentiation,
and migration (Xu et al., 1999). In the limb, attention has
been focused on the function of Fgf signalling in early limb
bud formation, such as limb bud induction and formation of
Copyright © 2001 by Academic Press. All rightthe ZPA and AER (Martin, 1998). We show here that Fgf4
presents a restricted expression pattern in myotubes in the
limb. Our data highlight a new role for Fgf4 in down-
regulating Frek transcripts.
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